Organization

Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences

2 abstracts

Abstract
Efficacy and safety of vebreltinib in patients with advanced NSCLC harboring MET exon 14-skipping: Results of 2.5-year follow-up in KUNPENG.
Org: Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Lung Cancer Center, Pulmonary and Critical Care Medicine, Zhongshan Hospital Affiliated to Fudan University, Shandong First Medical University and Shandong Academy of Medical Sciences,
Abstract
Preliminary dose escalation results from a first-in-human, phase I/II study of GB263T, a novel EGFR/cMET/cMET trispecific antibody, in patients with advanced EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC).
Org: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, Genesis Care North Shore, North Shore Health Hub, St Leonards, NSW, Australia,